Financhill
Back

Kymera Therapeutics Stock Predictions

Buy
58

KYMR
Kymera Therapeutics

Last Price:
33.09
Seasonality Move:
25.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Kymera Therapeutics Stock Forecast

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 8% based on the past 3 years of stock performance.
  • Kymera Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Kymera Therapeutics Stock Undervalued?
    The current Kymera Therapeutics [KYMR] share price is $32.96. The Score for KYMR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Kymera Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 8% based on the past 3 years of stock performance.

Kymera Therapeutics Stock Rating

Buy
58
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics overpriced?

  • Kymera Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Kymera Therapeutics Stock Price History

Is KYMR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com

52-Week Data

52-Week High:
45.31
52-Week Low:
9.60

Prediction Charts

Market Cap:
2.02B
Price in USD:
32.96
Volume:
310.11K
Beta:
2.23

Technical Analysis

SMA50:
35.42
SMA100:
36.43
SMA200:
27.67
52-Wk Change:
29.97%

Stock Predictions

  • Is Kymera Therapeutics stock public?
    Yes, Kymera Therapeutics is a publicly traded company.
  • What is the Kymera Therapeutics stock quote today?
    The Kymera Therapeutics stock price is 32.96 USD today.
  • How to buy Kymera Therapeutics stock online?
    You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-20 35.02 36.01 36.86 35.00
May-21 35.75 35.32 36.31 35.08
May-22 35.10 35.70 36.24 34.36
May-23 35.98 34.24 35.98 33.72
May-24 34.38 34.05 36.00 33.94
May-28 34.43 33.52 34.43 33.04
May-29 32.92 32.45 33.28 32.26
May-30 32.94 32.16 32.94 31.63
May-31 32.25 32.11 33.02 31.47
Jun-3 32.49 31.56 33.24 30.98
Jun-4 31.46 31.94 32.59 31.15
Jun-5 32.24 33.87 34.00 31.76
Jun-6 33.69 32.87 33.69 32.25
Jun-7 32.44 32.96 33.46 32.27

Kymera Therapeutics Earnings

Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kymera Therapeutics Forecast Revenue Growth

Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.31 per share.

* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.